S&P 500   4,626.38 (-0.62%)
DOW   34,888.22 (-0.71%)
QQQ   399.09 (-0.15%)
AAPL   160.48 (+0.15%)
MSFT   335.76 (-0.26%)
FB   334.15 (-1.15%)
GOOGL   2,905.50 (-0.18%)
AMZN   3,582.61 (+0.59%)
TSLA   1,157.26 (+1.78%)
NVDA   330.36 (-1.02%)
BABA   130.12 (-1.13%)
NIO   40.31 (-0.37%)
CGC   11.11 (+0.45%)
AMD   161.71 (-0.12%)
GE   97.13 (-1.29%)
MU   86.45 (+0.36%)
T   23.67 (-0.92%)
F   19.55 (-0.61%)
DIS   146.64 (-0.79%)
ACB   6.38 (-0.93%)
AMC   36.73 (-0.30%)
PFE   52.53 (+0.25%)
BA   196.10 (-1.21%)
S&P 500   4,626.38 (-0.62%)
DOW   34,888.22 (-0.71%)
QQQ   399.09 (-0.15%)
AAPL   160.48 (+0.15%)
MSFT   335.76 (-0.26%)
FB   334.15 (-1.15%)
GOOGL   2,905.50 (-0.18%)
AMZN   3,582.61 (+0.59%)
TSLA   1,157.26 (+1.78%)
NVDA   330.36 (-1.02%)
BABA   130.12 (-1.13%)
NIO   40.31 (-0.37%)
CGC   11.11 (+0.45%)
AMD   161.71 (-0.12%)
GE   97.13 (-1.29%)
MU   86.45 (+0.36%)
T   23.67 (-0.92%)
F   19.55 (-0.61%)
DIS   146.64 (-0.79%)
ACB   6.38 (-0.93%)
AMC   36.73 (-0.30%)
PFE   52.53 (+0.25%)
BA   196.10 (-1.21%)
S&P 500   4,626.38 (-0.62%)
DOW   34,888.22 (-0.71%)
QQQ   399.09 (-0.15%)
AAPL   160.48 (+0.15%)
MSFT   335.76 (-0.26%)
FB   334.15 (-1.15%)
GOOGL   2,905.50 (-0.18%)
AMZN   3,582.61 (+0.59%)
TSLA   1,157.26 (+1.78%)
NVDA   330.36 (-1.02%)
BABA   130.12 (-1.13%)
NIO   40.31 (-0.37%)
CGC   11.11 (+0.45%)
AMD   161.71 (-0.12%)
GE   97.13 (-1.29%)
MU   86.45 (+0.36%)
T   23.67 (-0.92%)
F   19.55 (-0.61%)
DIS   146.64 (-0.79%)
ACB   6.38 (-0.93%)
AMC   36.73 (-0.30%)
PFE   52.53 (+0.25%)
BA   196.10 (-1.21%)
S&P 500   4,626.38 (-0.62%)
DOW   34,888.22 (-0.71%)
QQQ   399.09 (-0.15%)
AAPL   160.48 (+0.15%)
MSFT   335.76 (-0.26%)
FB   334.15 (-1.15%)
GOOGL   2,905.50 (-0.18%)
AMZN   3,582.61 (+0.59%)
TSLA   1,157.26 (+1.78%)
NVDA   330.36 (-1.02%)
BABA   130.12 (-1.13%)
NIO   40.31 (-0.37%)
CGC   11.11 (+0.45%)
AMD   161.71 (-0.12%)
GE   97.13 (-1.29%)
MU   86.45 (+0.36%)
T   23.67 (-0.92%)
F   19.55 (-0.61%)
DIS   146.64 (-0.79%)
ACB   6.38 (-0.93%)
AMC   36.73 (-0.30%)
PFE   52.53 (+0.25%)
BA   196.10 (-1.21%)
NASDAQ:ACET

Adicet Bio News Headlines

$9.52
+0.12 (+1.28%)
(As of 11/29/2021 12:00 AM ET)
Add
Compare
Today's Range
$9.43
$9.91
50-Day Range
$7.01
$9.85
52-Week Range
$6.25
$17.80
Volume
194,300 shs
Average Volume
92,602 shs
Market Capitalization
$304.16 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.36

Media Mentions By Week



Adicet Bio Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ACET
News Sentiment

-0.68

0.27

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ACET Articles
This Week

1

0

ACET Articles
Average Week

Get Adicet Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACET and its competitors with MarketBeat's FREE daily newsletter.

Adicet Bio (NASDAQ:ACET) News Headlines Today

SourceHeadline
finance.yahoo.com logoAdicet Bio to Host Webcast Presentation of ADI-001 Interim Clinical Data in B Cell Non-Hodgkin’s Lymphoma
finance.yahoo.com - November 29 at 12:26 PM
finance.yahoo.com logoAdicet Bio (NASDAQ:ACET) shareholders have endured a 27% loss from investing in the stock a year ago
finance.yahoo.com - November 20 at 10:00 AM
MarketBeat logoAdicet Bio (NASDAQ:ACET) Receives "Buy" Rating from JMP Securities
americanbankingnews.com - November 15 at 6:26 AM
finance.yahoo.com logoAdicet Presents Preclinical Data for ADI-002, a GPC3-Targeted Development Candidate for Solid Tumors, at the SITC Annual Meeting
finance.yahoo.com - November 12 at 7:30 AM
MarketBeat logoAdicet Bio (NASDAQ:ACET) Issues Quarterly Earnings Results, Hits Expectations
americanbankingnews.com - November 11 at 2:26 PM
nasdaq.com logoAdicet Bio, Inc. (ACET) Reports Q3 Loss, Lags Revenue Estimates
nasdaq.com - November 10 at 10:40 PM
finance.yahoo.com logoAdicet Reports Third Quarter 2021 Financial Results and Provides Business Updates
finance.yahoo.com - November 10 at 5:39 PM
MarketBeat logoAdicet Bio, Inc. (NASDAQ:ACET) Receives Consensus Recommendation of "Buy" from Analysts
americanbankingnews.com - November 9 at 12:00 PM
finance.yahoo.com logoAdicet Bio to Participate in Stifel 2021 Virtual Healthcare Conference
finance.yahoo.com - November 8 at 9:17 AM
finance.yahoo.com logoAdicet Announces Trials in Progress Poster Presentation for ADI-001 at 2021 ASH Annual Meeting
finance.yahoo.com - November 4 at 9:11 AM
finance.yahoo.com logoCDR-Life Announces Expansion of Scientific Advisory Board
finance.yahoo.com - October 26 at 7:24 AM
finance.yahoo.com logoAdicet Announces Promotion of Blake Aftab, Ph.D. to Chief Scientific Officer
finance.yahoo.com - October 12 at 8:52 PM
finance.yahoo.com logoTwist Bioscience Collaborates with Adicet Bio to Accelerate Discovery of Gamma Delta T Cell Cancer Therapeutics
finance.yahoo.com - September 13 at 10:46 AM
finance.yahoo.com logoAdicet Bio Collaborates with Twist Bioscience to Accelerate Discovery of Gamma Delta T Cell Cancer Therapeutics
finance.yahoo.com - September 13 at 10:46 AM
nasdaq.com logoAdicet Bio, Inc. (ACET) Reports Q2 Loss, Tops Revenue Estimates
nasdaq.com - August 12 at 8:40 PM
finance.yahoo.com logoAdicet Reports Second Quarter 2021 Financial Results and Provides Business Updates
finance.yahoo.com - August 12 at 8:40 PM
finance.yahoo.com logoIs Adicet Bio Inc. (ACET) A Good Stock To Buy?
finance.yahoo.com - July 30 at 1:43 PM
uk.finance.yahoo.com logoAdicet Bio, Inc. (ACET)
uk.finance.yahoo.com - July 29 at 7:27 PM
finance.yahoo.com logoAdicet Bio Announces Formation of Scientific Advisory Board
finance.yahoo.com - July 15 at 9:23 AM
finance.yahoo.com logoAdicet Bio Added to the Russell 2000® Index
finance.yahoo.com - June 28 at 9:05 AM
barrons.com logoAdicet Bio Inc.
barrons.com - June 11 at 12:31 AM
nasdaq.com logoMoving Average Crossover Alert: Adicet Bio (ACET)
nasdaq.com - June 1 at 8:57 AM
finance.yahoo.com logoAdicet Reports First Quarter 2021 Financial Results and Provides Business Updates
finance.yahoo.com - May 17 at 7:31 AM
finance.yahoo.com logoAdicet Bio to Participate in Fireside Chat at the 7th Annual Truist Securities Life Sciences Summit
finance.yahoo.com - April 29 at 10:04 AM
finance.yahoo.com logoAdicet Bio to Participate in the Canaccord Genuity 2021 Horizons in Oncology Virtual Conference
finance.yahoo.com - April 23 at 10:11 AM
finance.yahoo.com logoAdicet Bio Appoints Dr. Blake Aftab as Vice President of Research
finance.yahoo.com - April 13 at 9:19 AM
finance.yahoo.com logoAdicet Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
finance.yahoo.com - March 11 at 4:58 PM
finance.yahoo.com logoAdicet Bio Announces Initiation of its First-in-Human Phase 1 Trial of ADI-001 for the Treatment of B Cell Non-Hodgkin's Lymphoma
finance.yahoo.com - March 10 at 8:13 AM
finance.yahoo.com logoAdicet Bio Appoints Dr. Andrew Sinclair to its Board of Directors
finance.yahoo.com - March 4 at 8:00 PM
finance.yahoo.com logoAdicet Bio, Inc. Announces Closing of $152 Million Public Offering and Concurrent Private Placement and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - February 16 at 8:28 AM
finance.yahoo.com logoAdicet Bio, Inc. Announces Pricing of $135 Million Public Offering of Common Stock and Concurrent Private Placement
finance.yahoo.com - February 10 at 8:23 AM
finance.yahoo.com logoAdicet Bio, Inc. Announces Proposed Public Offering of Common Stock and Concurrent Private Placement
finance.yahoo.com - February 9 at 5:22 PM
msn.com logoAdicet Bio (ACET) Surges: Stock Moves 5.9% Higher
msn.com - December 18 at 1:59 PM
finance.yahoo.com logoWe're Hopeful That Adicet Bio (NASDAQ:ACET) Will Use Its Cash Wisely
finance.yahoo.com - December 16 at 7:00 AM
finance.yahoo.com logoAdicet Bio to Participate in Fireside Chat at JMP Securities Hematology Summit
finance.yahoo.com - December 8 at 9:53 AM
finance.yahoo.com logoIs ACET A Good Stock To Buy Now?
finance.yahoo.com - December 8 at 4:52 AM
finance.yahoo.com logoAdicet Announces Appointment of Dr. Bastiano Sanna to its Board of Directors
finance.yahoo.com - December 1 at 8:52 AM
finance.yahoo.com logoAdicet Bio to Participate in Upcoming Investor Conferences
finance.yahoo.com - November 6 at 8:15 AM
finance.yahoo.com logoAdicet Reports Third Quarter 2020 Financial Results and Provides Business Update
finance.yahoo.com - November 5 at 7:41 PM
finance.yahoo.com logoAdicet Appoints Don Healey, Ph.D., as Chief Technology Officer
finance.yahoo.com - October 26 at 7:09 PM
bloomberg.com logoAdicet Bio Inc
bloomberg.com - October 25 at 12:28 AM
seekingalpha.com logoAdicet Bio on go with gamma delta T cell therapy in early-stage blood cancer study
seekingalpha.com - October 25 at 12:28 AM
forbes.com logoHisato Hamada Of Wagyumafia On Discovering Japan’s Greatest Culinary Artisans
forbes.com - October 23 at 8:49 AM
finance.yahoo.com logoAdicet Announces FDA Clearance of IND Application for First-in-Class Allogeneic CAR Gamma-Delta T Cell Therapy
finance.yahoo.com - October 22 at 9:00 AM
businesswire.com logoGlobal Benzocaine Market to Surpass US$ 155.3 Million by 2027, Says Coherent Market Insights (CMI) - Business Wire
businesswire.com - October 21 at 12:42 PM
forbes.com logoYour New Favorite Pumpkin Recipe Combines Two Classics: Balsamic Vinegar & Risotto - Forbes
forbes.com - October 9 at 11:59 PM
latimes.com logoHealing from turmoil, Kenosha voters have a message for America - Los Angeles Times
latimes.com - October 4 at 10:03 AM
latimes.com logoVoters worry about what comes after the election - Los Angeles Times
latimes.com - September 27 at 7:00 PM
businesswire.com logoGlucuronolactone Market Procurement Intelligence Report With COVID-19 Impact Analysis | Global Forecasts, 2020-2024 | SpendEdge - Business Wire
businesswire.com - September 24 at 8:36 AM
businesswire.com logoGlucuronolactone Market Procurement Intelligence Report With COVID-19 Impact Analysis | Global Forecasts, 2020-2024 | SpendEdge - Business Wire
businesswire.com - September 24 at 8:36 AM
Get Adicet Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACET and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 11/30/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.